However, whether PCSK9 genotype reduces mortality has not be conclusively shown.8, 41 Irrespective of the nature of the PCSK9 association with type 2 diabetes, large randomised trials should determine whether this relation also holds for PCSK9 monoclonal antibodies. Here, PCSK9 is linked to type 2 diabetes mellitus.